EB-2 NIWBiotech and pharmaIndividualDecided November 2023Sustained
Outcome: Sustained
NOV162023_09B5203
Merit and national importanceMetWell positionedMetBalance favors a waiverMet
Our summary
Biomedical engineer seeks NIW for EB-2 advanced degree classification to conduct cell and gene therapy research. Meets all three Dhanasar prongs: proposed endeavor has national importance, petitioner is well-positioned through credentials and research record, and waiving job offer benefits the United States.
Official PDF
Official PDF ↗Published by USCIS. The summary is ours, in our own words; the decision text is on uscis.gov.
What the AAO accepted
- Merit and national importance · Proposed cell and gene therapy research has both substantial merit and national importance in advancing STEM field.
- Well positioned · Ph.D. and Master of Science degrees, published research, grants, citations, and expert reference letters demonstrate expertise and track record.
- Balance favors a waiver · Biomedical engineer with STEM Ph.D. pursuing critical emerging technology; contributions benefit United States despite available qualified workers.
What was missing
Every criterion in the table was found met.
Criteria
| Criterion | Reading | Why |
|---|---|---|
 Merit and national importance | Met | Proposed cell and gene therapy research has both substantial merit and national importance in advancing STEM field. |
 Well positioned | Met | Ph.D. and Master of Science degrees, published research, grants, citations, and expert reference letters demonstrate expertise and track record. |
 Balance favors a waiver | Met | Biomedical engineer with STEM Ph.D. pursuing critical emerging technology; contributions benefit United States despite available qualified workers. |
A published decision describes one case. It is not legal advice and not a prediction for yours.